150 related articles for article (PubMed ID: 38745333)
21. Preoperative regional therapy for extremity sarcoma. A tricenter update.
Wanebo HJ; Temple WJ; Popp MB; Constable W; Aron B; Cunningham SL
Cancer; 1995 May; 75(9):2299-306. PubMed ID: 7712441
[TBL] [Abstract][Full Text] [Related]
22. Comparing Ultra-hypofractionated Proton versus Photon Therapy in Extremity Soft Tissue Sarcoma.
Thomas R; Chen H; Gogineni E; Halthore A; Floreza B; Esho-Voltaire T; Weaver A; Alcorn S; Ladra M; Li H; Deville C
Int J Part Ther; 2023; 9(3):30-39. PubMed ID: 36721484
[TBL] [Abstract][Full Text] [Related]
23. Is High-dose Radiation Therapy Associated With Early Revision Due to Aseptic Loosening in Patients With a Sarcoma of the Lower Extremities Reconstructed With a Cemented Endoprosthesis?
Arnold MT; Geiger EJ; Hart C; Greig D; Trikha R; Sekimura T; Eckardt JJ; Bernthal NM
Clin Orthop Relat Res; 2023 Mar; 481(3):475-487. PubMed ID: 35977001
[TBL] [Abstract][Full Text] [Related]
24. Is 5 the New 25? Long-Term Oncologic Outcomes From a Phase II, Prospective, 5-Fraction Preoperative Radiation Therapy Trial in Patients With Localized Soft Tissue Sarcoma.
Bedi M; Singh R; Charlson JA; Kelly T; Johnstone C; Wooldridge A; Hackbarth DA; Moore N; Neilson JC; King DM
Adv Radiat Oncol; 2022; 7(3):100850. PubMed ID: 35647402
[TBL] [Abstract][Full Text] [Related]
25. Function Preservation After Conservative Resection and Radiotherapy for Soft-tissue Sarcoma of the Distal Extremity: Utility and Application of the Toronto Extremity Salvage Score (TESS).
Cassidy RJ; Indelicato DJ; Gibbs CP; Scarborough MT; Morris CG; Zlotecki RA
Am J Clin Oncol; 2016 Dec; 39(6):600-603. PubMed ID: 25036470
[TBL] [Abstract][Full Text] [Related]
26. Influence of site on the therapeutic ratio of adjuvant radiotherapy in soft-tissue sarcoma of the extremity.
Alektiar KM; Brennan MF; Singer S
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):202-8. PubMed ID: 16111590
[TBL] [Abstract][Full Text] [Related]
27. Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies.
Badiyan SN; Rutenberg MS; Hoppe BS; Mohindra P; Larson G; Hartsell WF; Tsai H; Zeng J; Rengan R; Glass E; Katz S; Vargas C; Feigenberg SJ; Simone CB
Pract Radiat Oncol; 2019; 9(4):280-288. PubMed ID: 30802618
[TBL] [Abstract][Full Text] [Related]
28. Predictors of oncologic outcome in patients with and without flap reconstruction after extremity and truncal soft tissue sarcomas.
Dadras M; Koepp P; Wallner C; Wagner JM; Sogorski A; Lehnhardt M; Harati K; Behr B
J Plast Reconstr Aesthet Surg; 2020 Jul; 73(7):1239-1252. PubMed ID: 32245732
[TBL] [Abstract][Full Text] [Related]
29. Phase 1 adaptive dose-finding study of neoadjuvant gemcitabine combined with radiation therapy for patients with high-risk extremity and trunk soft tissue sarcoma.
Tseng WW; Zhou S; To CA; Thall PF; Lazar AJ; Pollock RE; Lin PP; Cormier JN; Lewis VO; Feig BW; Hunt KK; Ballo MT; Patel S; Pisters PW
Cancer; 2015 Oct; 121(20):3659-67. PubMed ID: 26177983
[TBL] [Abstract][Full Text] [Related]
30. Neoadjuvant hypofractionated radiotherapy and chemotherapy for extremity soft tissue sarcomas: Safety, feasibility, and early oncologic outcomes of a phase 2 trial.
Gobo Silva ML; Lopes de Mello CA; Aguiar Junior S; D'Almeida Costa F; Stevanato Filho PR; Santoro Bezerra T; Nakagawa SA; Nascimento AG; Werneck da Cunha I; Spencer Sobreira Batista RM; Nicolau Daher UR; Da Cruz Formiga MN; Germano JN; Catin Kupper BE; De Assis Pellizzon AC; Lopes A
Radiother Oncol; 2021 Jun; 159():161-167. PubMed ID: 33798613
[TBL] [Abstract][Full Text] [Related]
31. Dosimetric comparison between proton beam therapy, intensity modulated radiation therapy, and 3D conformal therapy for soft tissue extremity sarcoma.
Laughlin BS; Golafshar M; Prince M; Liu W; Kutyreff CJ; Ahmed SK; Vern Gross TZ; Haddock M; Petersen I; DeWees TA; Ashman JB
Acta Oncol; 2023 May; 62(5):473-479. PubMed ID: 37154167
[TBL] [Abstract][Full Text] [Related]
32. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial.
Gronchi A; Ferrari S; Quagliuolo V; Broto JM; Pousa AL; Grignani G; Basso U; Blay JY; Tendero O; Beveridge RD; Ferraresi V; Lugowska I; Merlo DF; Fontana V; Marchesi E; Donati DM; Palassini E; Palmerini E; De Sanctis R; Morosi C; Stacchiotti S; Bagué S; Coindre JM; Dei Tos AP; Picci P; Bruzzi P; Casali PG
Lancet Oncol; 2017 Jun; 18(6):812-822. PubMed ID: 28499583
[TBL] [Abstract][Full Text] [Related]
33. Excellent local control with IOERT and postoperative EBRT in high grade extremity sarcoma: results from a subgroup analysis of a prospective trial.
Roeder F; Lehner B; Schmitt T; Kasper B; Egerer G; Sedlaczek O; Grüllich C; Mechtersheimer G; Wuchter P; Hensley FW; Huber PE; Debus J; Bischof M
BMC Cancer; 2014 May; 14():350. PubMed ID: 24885755
[TBL] [Abstract][Full Text] [Related]
34. Preoperative ultra-hypofractionation radiotherapy in extremity/trunk wall soft tissue sarcoma - A meta-analysis of prospective studies.
Kao YS
Cancer Radiother; 2023 Apr; 27(2):96-102. PubMed ID: 36028419
[TBL] [Abstract][Full Text] [Related]
35. Long-term results of prospective trial of surgery alone with selective use of radiation for patients with T1 extremity and trunk soft tissue sarcomas.
Pisters PW; Pollock RE; Lewis VO; Yasko AW; Cormier JN; Respondek PM; Feig BW; Hunt KK; Lin PP; Zagars G; Wei C; Ballo MT
Ann Surg; 2007 Oct; 246(4):675-81; discussion 681-2. PubMed ID: 17893504
[TBL] [Abstract][Full Text] [Related]
36. The Oncologic Impact of Postoperative Complications Following Resection of Truncal and Extremity Soft Tissue Sarcomas.
Broecker JS; Ethun CG; Monson DK; Lopez-Aguiar AG; Le N; McInnis M; Godette K; Reimer NB; Oskouei SV; Delman KA; Staley CA; Maithel SK; Cardona K
Ann Surg Oncol; 2017 Nov; 24(12):3574-3586. PubMed ID: 28895084
[TBL] [Abstract][Full Text] [Related]
37. Adequate Local Control in High-Risk Soft Tissue Sarcoma of the Extremity Treated with Surgery Alone at a Reference Centre: Should Radiotherapy Still be a Standard?
Fiore M; Ford S; Callegaro D; Sangalli C; Colombo C; Radaelli S; Frezza AM; Renne SL; Casali PG; Gronchi A
Ann Surg Oncol; 2018 Jun; 25(6):1536-1543. PubMed ID: 29470819
[TBL] [Abstract][Full Text] [Related]
38. The influence of time interval between preoperative radiation and surgical resection on the development of wound healing complications in extremity soft tissue sarcoma.
Griffin AM; Dickie CI; Catton CN; Chung PW; Ferguson PC; Wunder JS; O'Sullivan B
Ann Surg Oncol; 2015 Sep; 22(9):2824-30. PubMed ID: 26018726
[TBL] [Abstract][Full Text] [Related]
39. An effective preoperative three-dimensional radiotherapy target volume for extremity soft tissue sarcoma and the effect of margin width on local control.
Kim B; Chen YL; Kirsch DG; Goldberg SI; Kobayashi W; Kung JH; Wolfgang JA; Doppke K; Rosenberg AE; Nielsen GP; Raskin KA; Springfield DS; Schwab JH; Gebhardt MC; Yoon SS; Hornicek FJ; DeLaney TF
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):843-50. PubMed ID: 20005638
[TBL] [Abstract][Full Text] [Related]
40. Hypofractionated radiotherapy for non-metastatic bone and soft tissue sarcomas.
Yuce Sari S; Cengiz M; Dauletkazin A; Yazici G; Gultekin M; Hurmuz P; Yildiz F; Zorlu F; Gurkaynak M; Akyol F; Ozyigit G
Cancer Radiother; 2019 Dec; 23(8):853-859. PubMed ID: 31640927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
